ELIZABETH RAMSEY: Open Payments
NPI 1477835494 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 84 payments from 18 companies in 2025. Trend: 2023 $1,101 · 2024 $1,225 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $262 |
| PFIZER INC. | 14 | $195 |
| ABBVIE INC. | 19 | $157 |
| Novo Nordisk Inc | 9 | $150 |
| Lilly USA, LLC | 7 | $110 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| Amgen Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| Abbott Laboratories | 2 | $41 |
Products named: AIRSUPRA, BREZTRI, Wegovy, PREVNAR 20, GEMTESA, MOUNJARO, VRAYLAR, QULIPTA.
Industry payments across KY — which companies pay providers there.
